Literature DB >> 19389032

Time course and etiology of death in patients with severe anemia.

Aaron A R Tobian1, Paul M Ness, Helaine Noveck, Jeffrey L Carson.   

Abstract

BACKGROUND: Mortality increases as hemoglobin (Hb) levels fall. Among severely anemic patients, the clinical course, cause of death, and whether there are any warning signs before death are unknown. STUDY DESIGN AND METHODS: A retrospective cohort study was performed of surgical patients who refused red blood cell transfusions for religious reasons and died with a Hb concentration 6 g/dL or less. Mortality was defined as death that occurred during hospitalization.
RESULTS: Among the 1958 Jehovah's Witness patients that had surgery, 117 (5.6%) had a postoperative Hb level of 6 g/dL or less and 39 (33.3%) of these individuals died in the hospital. The median number of days from surgery to the lowest Hb level was 3 days (range, 0-22 days; interquartile range, 1-8 days) and from the lowest postoperative Hb level to death was 2 days (range, 0-40 days; interquartile range, 1-12 days). Individuals with a Hb level of 2.0 g/dL or less had on median 1.0 (interquartile range, 0.5-1.5) day from their lowest Hb to death while individuals with their lowest Hb ranging between 4.1 and 5.0 g/dL had on median 11 (interquartile range, 1-23) days from their lowest Hb to death. Except for anemia, no single etiology of death was predominant.
CONCLUSIONS: While there does not appear to be any single etiology that can be predictive or preventative of mortality for anemic patients, individuals with very low Hb concentrations often do not die quickly. Thus, there appears to be a potential time window where transfusion medicine physicians may intervene.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19389032     DOI: 10.1111/j.1537-2995.2009.02134.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  7 in total

1.  High-risk anaemic Jehovah's Witness patients should be managed in the intensive care unit.

Authors:  Andrei M Beliaev
Journal:  Blood Transfus       Date:  2013-03-19       Impact factor: 3.443

2.  Low-dose erythropoietin treatment is not associated with clinical benefits in severely anaemic Jehovah's Witnesses: a plea for a change.

Authors:  Andrei M Beliaev; Sara J Allen; Paget Milsom; Parma Nand; Warren M Smith; Colleen J Bergin
Journal:  Blood Transfus       Date:  2016-11-15       Impact factor: 3.443

Review 3.  RBC Transfusion Triggers: Is There Anything New?

Authors:  Tina Tomic Mahecic; Martin Dünser; Jens Meier
Journal:  Transfus Med Hemother       Date:  2020-09-24       Impact factor: 3.747

4.  Non-Parametric Combined Reference Regions and Prediction of Clinical Risk.

Authors:  Roy Malka; Carlo Brugnara; Ron Cialic; John M Higgins
Journal:  Clin Chem       Date:  2020-02-01       Impact factor: 8.327

5.  Life-threatening anemia due to uterine fibroids: A case series.

Authors:  Michiko Kawano; Mamiko Okamoto; Mitsutake Yano; Yasushi Kawano
Journal:  Exp Ther Med       Date:  2022-09-12       Impact factor: 2.751

6.  Recommendations on RBC Transfusions in Critically Ill Children With Acute Respiratory Failure From the Pediatric Critical Care Transfusion and Anemia Expertise Initiative.

Authors:  Pierre Demaret; Guillaume Emeriaud; Nabil E Hassan; Martin C J Kneyber; Stacey L Valentine; Scot T Bateman; Marisa Tucci
Journal:  Pediatr Crit Care Med       Date:  2018-09       Impact factor: 3.624

Review 7.  Patient blood management - a new paradigm for transfusion medicine?

Authors:  A Thomson; S Farmer; A Hofmann; J Isbister; A Shander
Journal:  ISBT Sci Ser       Date:  2009-10-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.